Occudo Quantitative Strategies’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Occudo Quantitative Strategies’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-29,562	Closed	-$443K	–	1282
2023 Q3	$443K	Buy	+29,562	New	+$615K	0.06%	543
2023 Q2	–	Sell	-43,307	Closed	-$1.69M	–	1352
2023 Q1	$1.69M	Buy	+43,307	New	+$2.12M	0.15%	189
2021 Q3	–	Sell	-5,064	Closed	-$242K	–	1182
2021 Q2	$242K	Sell	5,064 -270	-5%	-$13.8K	0.04%	675
2021 Q1	$270K	Buy	5,334 +429	+9%	+$23.8K	0.06%	529
2020 Q4	$309K	Buy	+4,905	New	+$304K	0.1%	406

Other funds holding SILK

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Occudo Quantitative Strategies's SILK Position: Q4 2023 in Review

Occudo Quantitative Strategies sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q4 2023, closing a stake of 29,562 shares — an estimated $443K sold.

Occudo Quantitative Strategies first reported a position in SILK in Q4 2020 and held it in 5 quarters. The position peaked at $1.69M in Q1 2023. 133 funds tracked by Wall St. Rank hold SILK as of Q4 2023.

Occudo Quantitative Strategies reported no remaining Silk Road Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Occudo Quantitative Strategies sold 29,562 Silk Road Medical, Inc. Common Stock shares in Q4 2023, an estimated $443K.
Occudo Quantitative Strategies first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
Occudo Quantitative Strategies's Silk Road Medical, Inc. Common Stock position peaked at $1.69M in Q1 2023.
133 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q4 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.